Publications by authors named "Teruki Kobayashi"

Esophageal cancer remains a highly aggressive malignancy with a poor prognosis, despite ongoing advancements in treatments such as immunotherapy. The tumor microenvironment, particularly cancer-associated fibroblasts (CAF), plays a crucial role in driving the aggressiveness of esophageal cancer. In a previous study utilizing human-derived xenograft models, we successfully developed a novel cancer treatment that targeted CAFs with near-infrared photoimmunotherapy (NIR-PIT), as an adjuvant therapy.

View Article and Find Full Text PDF

Background: Cancer-associated fibroblasts (CAFs) in the tumor microenvironment (TME) play a critical role in tumor immunosuppression. However, targeted depletion of CAFs is difficult due to their diverse cells of origin and the resulting lack of specific surface markers. Near-infrared photoimmunotherapy (NIR-PIT) is a novel cancer treatment that leads to rapid cell membrane damage.

View Article and Find Full Text PDF
Article Synopsis
  • The PD-1/PD-L1 pathway significantly contributes to tumor immunosuppression, while cancer-associated fibroblasts (CAFs) also promote tumor growth.
  • An analysis of 140 esophageal cancer cases revealed a correlation between PD-L1 expression and CAF markers, indicating that higher PD-L1 levels in CAFs are linked to poorer patient survival.
  • Experimental studies showed that targeting PD-L1 can lead to increased cancer cell death and enhance immune responses, suggesting that PD-L1-expressing CAFs are potential therapeutic targets to improve cancer treatment outcomes.
View Article and Find Full Text PDF

Esophageal cancer is one of the most aggressive tumors, and the outcome remains poor. One contributing factor is the presence of tumors that are less responsive or have increased malignancy when treated with conventional chemotherapy, radiotherapy, or a combination of these. Cancer-associated fibroblasts (CAFs) play an important role in the tumor microenvironment.

View Article and Find Full Text PDF

The granulocyte-colony-stimulating factor (G-CSF) glycoprotein stimulates precursor cell proliferation and differentiation in the bone marrow. Various G-CSF-producing tumors have been reported; they showed early progression and an extremely poor prognosis. Here, we report a case of G-CSF-producing gallbladder cancer with lymph node metastasis.

View Article and Find Full Text PDF
Article Synopsis
  • - Cancer-associated fibroblasts (CAFs) contribute significantly to tumor growth and immunosuppression, largely influenced by interleukin-6 (IL-6), which is linked to a more aggressive tumor environment.
  • - Anti-IL-6 receptor antibodies were investigated as a potential systemic therapy to counteract the effects of IL-6 and CAFs, demonstrating the ability to inhibit tumor progression in mouse models by regulating the activation of HIF1α, a key factor in cell growth and survival.
  • - Clinical findings revealed a strong correlation between IL-6 expression and worse patient outcomes, indicating that targeting IL-6 could potentially enhance cancer treatment by alleviating immune suppression and improving survival rates.
View Article and Find Full Text PDF
Article Synopsis
  • Cancer-associated fibroblasts (CAFs) are crucial for tumor progression, and a new therapy called dual-targeted near-infrared photoimmunotherapy (NIR-PIT) targets both cancer cells and CAFs to improve treatment effectiveness.
  • A study involving 132 esophageal cancer cases found that high levels of markers like epidermal growth factor receptor (EGFR) and fibroblast activation protein (FAP) were linked to poorer patient survival, while HER2 status showed no significant effect.
  • Dual-targeted NIR-PIT demonstrated more effective tumor suppression and improved outcomes in experimental models compared to single-targeted NIR-PIT, suggesting it could be a promising strategy for cancer therapy.
View Article and Find Full Text PDF

Cancer-associated fibroblasts (CAFs) have an important role in the tumor microenvironment. CAFs have the multifunctionality which strongly support cancer progression and the acquisition of therapeutic resistance by cancer cells. Near-infrared photoimmunotherapy (NIR-PIT) is a novel cancer treatment that uses a highly selective monoclonal antibody (mAb)-photosensitizer conjugate.

View Article and Find Full Text PDF

A metal-mediated base pair, composed of two ligand-bearing nucleotides and a bridging metal ion, is one of the most promising components for developing DNA-based functional molecules. We have recently reported an enzymatic method to synthesize hydroxypyridone (H)-type ligand-bearing artificial DNA strands. Terminal deoxynucleotidyl transferase (TdT), a template-independent DNA polymerase, was found to oligomerize H nucleotides to afford ligand-bearing DNAs, which were subsequently hybridized through copper-mediated base pairing (H-Cu(II)-H).

View Article and Find Full Text PDF

We have developed a novel method to synthesise artificial ligand-bearing DNAs utilising a template-independent DNA polymerase. Hydroxypyridone ligand-bearing nucleotides () were successively appended to DNA primers by the enzyme. The resulting strands, tailed with nucleotides, formed Cu(II)-mediated metallo-DNA duplexes through the formation of metal-mediated artificial base pairs (H-Cu(II)-H).

View Article and Find Full Text PDF

We have developed plasma chemical vaporization machining by using a microelectrode for the fabrication of small complex-shaped optical surfaces. In this method, a 0.5 mm diameter pipe microelectrode, from which processing gas is drawn in, generates a small localized plasma that is scanned over a workpiece under numerical computer control to shape a desired surface.

View Article and Find Full Text PDF

We figure optical surfaces by plasma chemical vaporization machining (CVM) with a pipe electrode, in which an rf plasma generated at the electrode tip under approximately atmospheric pressure moves over the surfaces. We propose a shaping method in which the movement of plasma on the surfaces can be determined. Flat and aspheric surfaces are successfully figured with the desired peak-to-valley shape accuracy of 0.

View Article and Find Full Text PDF